高密度脂蛋白胆固醇和多发性骨髓瘤:一个系统的审查和元分析
Anastasios Makris1,2, Antonia Pagkali1, Emmanouil Nikolousis1
1School of Medicine, European University Cyprus, Nicosia, Cyprus.
Atherosclerosis plus
|October 2, 2023
概括
多发性骨髓瘤患者的高密度脂蛋白胆固醇 (HDL-C) 和其他脂质标记物显著降低. 这些发现表明,将脂质资料纳入多发性骨髓瘤患者评估中至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床生物化学 临床生物化学
背景情况:
- 多发性骨髓瘤 (MM) 是一种具有复杂病理生理学的血液性恶性瘤.
- 在各种癌症中,越来越多地认识到脂质代谢的改变.
- 高密度脂蛋白胆固醇 (HDL-C) 和MM之间的特定关联需要进行系统的调查.
研究的目的:
- 对HDL-C和MM之间的关联进行系统审查和元分析.
- 评估HDL-C和其他脂质参数在MM患者中的作用.
- 在多发性骨髓瘤的背景下,综合现有关于脂质谱的证据.
主要方法:
- 在PubMed和Cochrane图书馆数据库中进行系统的文献搜索,截至2022年9月.
- 包括前性和后性研究,检查MM患者的HDL-C.
- HDL-C的定性合成和元分析意味着MM病例和对照之间的差异.
主要成果:
- 系统性审查包括14项研究 (895名MM患者).
- 对10项研究 (17,213名参与者) 的分析显示,与对照组相比,MM患者的HDL-C水平显著降低 (MD: -13.07 mg/dl).
- 总胆固醇 (TC) 和阿波利波蛋白AI (apoA-I) 的显著下降也被观察到,但LDL-C或甘油三的显著下降并没有.
结论:
- 在多发性髓瘤患者中,HDL-C,TC和apoA-I水平显著降低.
- 这些脂质谱的变化值得在MM的临床评估和管理中加以考虑.
- 进一步的研究可能会阐明这些脂质变化对MM的预后和诊断影响.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
691
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
691
Cholesterol: Significance and Regulation
572
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
572
